Epigenetics: A primer for clinicians
- PMID: 26969414
- PMCID: PMC5737767
- DOI: 10.1016/j.blre.2016.02.002
Epigenetics: A primer for clinicians
Abstract
With recent advances in cellular biology, we now appreciate that modifications to DNA and histones can have a profound impact on transcription and function, even in the absence of changes to DNA sequence. These modifications, now commonly referred to as "epigenetic" alterations, have changed how we understand cell behavior, reprogramming and differentiation and have provided significant insight into the mechanisms underlying carcinogenesis. Epigenetic alterations, to this point, are largely identified by changes in DNA methylation and hydroxymethylation as well as methylation, acetylation, and phosphorylation of histone tails. These modifications enable significant flexibility in gene expression, rather than just turning genes "ON" or "OFF." Herein we describe the epigenetic landscape in the regulation of gene expression with a particular focus on interrogating DNA methylation in myeloid malignancy.
Keywords: 5-Hydroxymethylcytosine (5HmC); 5-Methylcytosine (5mC); Cytosine phospho-guanine (CpG); DNA methyltransferases (DNMTs); DNMT inhibitor (DNMTi); Hypomethylating agent (HMA); Ten eleven translocation (TET).
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Hotchkiss RD. The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J Biol Chem. 1948;175(1):315–332. - PubMed
-
- Sober HA. Handbook of Biochemistry. 2d. Cleveland, OH: Chemical Rubber Company; 1970.
-
- Hall R. The Modified Nuclesides in Nucleic Acids. New York: Columbia Univeristy Press; 1972.
-
- Gruenbaum Y, Stein R, Cedar H, Razin A. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 1981;124(1):67–71. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
